Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News

Congo's Ebola Outbreak Spreads to Two More Provinces

The Ebola outbreak in the Democratic Republic of Congo has spread to two more northeastern provinces, Haut-Uele ⁠and Tshopo, the country's public health institute said in...

‘Super Movers’ May Have Slower Cognitive Decline

Fast-walking ‘super movers’ aged 80 years or older have about half the risk for cognitive impairment but no less Alzheimer’s disease pathology.

Sanofi to Stop Disparaging Rival Flu Vaccine to Stave Off EU Antitrust Fine

French pharmaceutical company Sanofi has offered to state publicly that ⁠a rival flu vaccine is as effective as its own, EU antitrust regulators said on Wednesday of the...

India's Dr Reddy's Says Semaglutide Shipping Disruption to Last Until At Least Late October

India's Dr Reddy's Laboratories said on Thursday that supplies of its generic semaglutide would remain unavailable in India and face disruptions in Canada until at least...

RSV Preventive Strategies Tied to Fewer Bronchiolitis Cases

Administration of nirsevimab and RSV vaccination in pregnant women are tied to significant reductions in hospitalized days and oxygen requirements among infants with bronchiolitis.

Light Activity Pays Off for COPD Survival

New data show that patients need not exercise intensely to improve outcomes.

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Latest News

The Ebola outbreak in the Democratic Republic of Congo has spread to two more northeastern provinces, Haut-Uele ⁠and Tshopo, the country's public health institute said in...

Fast-walking ‘super movers’ aged 80 years or older have about half the risk for cognitive impairment but no less Alzheimer’s disease pathology.

French pharmaceutical company Sanofi has offered to state publicly that ⁠a rival flu vaccine is as effective as its own, EU antitrust regulators said on Wednesday of the...

India's Dr Reddy's Laboratories said on Thursday that supplies of its generic semaglutide would remain unavailable in India and face disruptions in Canada until at least...

Administration of nirsevimab and RSV vaccination in pregnant women are tied to significant reductions in hospitalized days and oxygen requirements among infants with bronchiolitis.

New data show that patients need not exercise intensely to improve outcomes.

News All Time

When AI Makes the Call, Doctors May Take the Blame

For all its promise and computational power, will AI in clinical medicine overcome physicians’ concerns?

New Artificial Neurons Cause Living Brain Cells to Fire

An array of artificial neurons printed on a flexible wafer produce spiking waveforms closely matching biological action — and drive living mouse brain cells to fire.

China Outpacing Europe in Drug Innovation, Pfizer Executive

China has pulled ahead of Europe in pharmaceutical innovation and drug development, a senior Pfizer executive ⁠said on Tuesday.

PCR Testing Finds Infections in Lung Transplant Recipients

Tests show greatest value when used alongside imaging.

European Patient Access to New Drugs Worsens

Patient access to new medicines is worsening across Europe, the region's main pharmaceuticals industry ⁠lobby group said.

Wrist Air Samplers Detect Virus Exposure in Kids With Asthma

Devices may inform disease prevention strategies by providing community-level data.

Colistin MIC Affects Outcomes in Gram-Negative Infections

In carbapenem-resistant gram-negative infections caused by pathogens for which the colistin MIC is 2 mg/L, the colistin-meropenem combination is linked to better clinical outcomes than colistin alone.

What 300,000 Implants Say About Light Adjustable Lens

An intraocular lens that can be adjusted after cataract surgery has better outcomes for meeting target vision than other lenses, but patient selection and involvement are key.

Parkinson’s Disease Deaths Decline Among Older US Adults

Death rates from Parkinson’s disease among US older adults decline in 2024 following a steady rise from 2014 to 2021, new data show.

Sri Lanka Battles Surge in Dengue Fever, With More Than 44,000 Cases So Far This Year

Sri Lanka is battling the worst outbreak of mosquito-borne dengue fever in years, with more than ⁠44,000 cases and 28 deaths recorded since January, an official said on...

More Than 70 Congo Medics Infected With Ebola Since Outbreak Started, WHO Says

A senior World Health Organization official said on Friday that 75 ⁠medics in the Democratic Republic of Congo had been infected with Ebola and 17 of ⁠them had died since...

US Progesterone Supplies Tighten as Menopause Treatment Demand Grows

U.S. supplies of progesterone are coming under strain, with patients, clinicians, and pharmacists reporting recent intermittent shortages of oral versions of the hormone...

Moderna's MRNA Flu Vaccine Backed by FDA Advisers

Advisers to the U.S. Food and Drug Administration on Thursday backed approval of Moderna's flu vaccine for adults aged 50 and older, saying its benefits outweigh its risks,...

Mycobacteria May Predict Graft Failure After Lung Transplant

Early isolation can be a biomarker for patients at increased risk for poor outcomes.

Safety Gaps Put Patients at Risk Across NHS Pathways

NHS patients may face delays in accessing specialist care because of accountability failures and data-sharing gaps across regional pathways, HSSIB has warned.

Moderna Flu Shot Data May Support Use in Older Adults, US FDA Staff Says

U.S. Food and Drug Administration staff reviewers said on Tuesday data demonstrating an immune response to Moderna's flu shot may support effectiveness in adults ⁠65 years...